Skip to content

Construction of a National Environment-Diabetes Clinical Dynamic Cohort Big Data Platform

Construction of a National Environment-Diabetes Clinical Dynamic Cohort Big Data Platform

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106835
Enrollment
Unknown
Registered
2025-07-30
Start date
2025-10-15
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High blood sugar, diabetes

Interventions

Observation group:None

Sponsors

Fujian Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. People with elevated blood sugar: (1) Impaired fasting blood glucose (IFG): fasting blood glucose >=6.1 mmol/L and =7.8 mmol/L and =7.0 mmol/L; (2) OGTT 2-hour blood glucose > = 11.1 mmol/L; (3) Glycated hemoglobin (HbA1c) > = 6.5%; (4) Diagnosed with diabetes and receiving hypoglycemic therapy (medical records or medication evidence required).

Exclusion criteria

Exclusion criteria: 1. Unable to provide informed consent: including those with cognitive impairment, unconsciousness, or no guardian to sign the consent form; 2. Type I diabetes mellitus (T1DM): subjects with confirmed or suspected T1DM based on clinical diagnosis (insulin-dependent onset ketosis tendency) and laboratory tests (glutamate decarboxylase antibody/GAD-Ab positive); 3. Gestational diabetes mellitus (GDM): hyperglycemic status first diagnosed during pregnancy; 4. Secondary diabetes: after pancreatectomy, Cushing's syndrome, other clear secondary factors (such as long-term glucocorticoid use, hemochromatosis, etc.); 5. Patients with severe comorbidities: (1) End-stage renal disease: estimated glomerular filtration rate (eGFR) =5 years); (3) Mental illness that cannot cooperate with follow-up: including major depression, schizophrenia and other diseases that prevent the completion of questionnaires or examinations.

Design outcomes

Primary

MeasureTime frame
Detect environmental endocrine disruptors in blood and urine;

Countries

China

Contacts

Public ContactGang Chen

Fujian Provincial Hospital

chengangfj@163.com+86 13509337027

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026